{"title":"解决导管锁定疗法:肝素与达巴万星一起在溶液中冷冻时是否会降低达巴万星的生物活性?","authors":"","doi":"10.1016/j.eimc.2024.02.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The possible use of dalbavancin as a catheter lock solution was previously demonstrated by our study group. However, it was needed to assess whether heparin could affect dalbavancin bioactivity during freezing storage.</div></div><div><h3>Methods</h3><div>We tested the bioactivity of a dalbavancin<!--> <!-->+<!--> <!-->heparin (DH) vs. dalbavancin (<em>D</em><span>) against Staphylococcal biofilms comparing DH median value of cfu counts and metabolic activity with that obtained for </span><em>D</em> before and during storage under freezing up to 6 months.</div></div><div><h3>Results</h3><div>Despite there was a slight decrease in the median percentage reduction of metabolic activity at month 3 in <span><span>Staphylococcus epidermidis</span></span><span> between DH and </span><em>D</em> (97.6 vs. 100, <em>p</em> <!-->=<!--> <!-->0.037), considering the clinical criteria, no significant reduction in any of the variables tested was observed at the end of the experiment between <em>D</em> and DH solutions.</div></div><div><h3>Conclusion</h3><div>The addition of heparin to a dalbavancin lock solution did not affect its bioactivity against staphylococcal biofilms irrespective of its preservation time under freezing.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 8","pages":"Pages 435-438"},"PeriodicalIF":2.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?\",\"authors\":\"\",\"doi\":\"10.1016/j.eimc.2024.02.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>The possible use of dalbavancin as a catheter lock solution was previously demonstrated by our study group. However, it was needed to assess whether heparin could affect dalbavancin bioactivity during freezing storage.</div></div><div><h3>Methods</h3><div>We tested the bioactivity of a dalbavancin<!--> <!-->+<!--> <!-->heparin (DH) vs. dalbavancin (<em>D</em><span>) against Staphylococcal biofilms comparing DH median value of cfu counts and metabolic activity with that obtained for </span><em>D</em> before and during storage under freezing up to 6 months.</div></div><div><h3>Results</h3><div>Despite there was a slight decrease in the median percentage reduction of metabolic activity at month 3 in <span><span>Staphylococcus epidermidis</span></span><span> between DH and </span><em>D</em> (97.6 vs. 100, <em>p</em> <!-->=<!--> <!-->0.037), considering the clinical criteria, no significant reduction in any of the variables tested was observed at the end of the experiment between <em>D</em> and DH solutions.</div></div><div><h3>Conclusion</h3><div>The addition of heparin to a dalbavancin lock solution did not affect its bioactivity against staphylococcal biofilms irrespective of its preservation time under freezing.</div></div>\",\"PeriodicalId\":11608,\"journal\":{\"name\":\"Enfermedades infecciosas y microbiologia clinica\",\"volume\":\"42 8\",\"pages\":\"Pages 435-438\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Enfermedades infecciosas y microbiologia clinica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0213005X24002039\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X24002039","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?
Introduction
The possible use of dalbavancin as a catheter lock solution was previously demonstrated by our study group. However, it was needed to assess whether heparin could affect dalbavancin bioactivity during freezing storage.
Methods
We tested the bioactivity of a dalbavancin + heparin (DH) vs. dalbavancin (D) against Staphylococcal biofilms comparing DH median value of cfu counts and metabolic activity with that obtained for D before and during storage under freezing up to 6 months.
Results
Despite there was a slight decrease in the median percentage reduction of metabolic activity at month 3 in Staphylococcus epidermidis between DH and D (97.6 vs. 100, p = 0.037), considering the clinical criteria, no significant reduction in any of the variables tested was observed at the end of the experiment between D and DH solutions.
Conclusion
The addition of heparin to a dalbavancin lock solution did not affect its bioactivity against staphylococcal biofilms irrespective of its preservation time under freezing.
期刊介绍:
Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.